Research Article

Assessment of MRI-Based Radiomics in Preoperative T Staging of Rectal Cancer: Comparison between Minimum and Maximum Delineation Methods

Table 1

Pathological characteristics of the patients.

VariablesTraining setValidation set value
()()

GenderMale94 (61.8%)109 (66.1%)0.434
Female58 (38.2%)56 (33.9%)
Age (years)0.147
BMI (kg/m2)0.397
Tumor locationUpper36 (23.7%)32 (19.4%)0.648
Middle92 (60.5%)105 (63.6%)
Lower24 (15.8%)28 (17.0%)
Histological typeAdenocarcinoma131 (86.2%)146 (88.5%)0.325
Mucinous adenocarcinoma15 (9.9%)17 (10.3%)
Signet ring cell carcinoma6 (3.9%)2 (1.2%)
DifferentiationHigh20 (13.2%)17 (10.3%)0.713
Moderate112 (73.7%)127 (77.0%)
Poor20 (13.2%)21 (12.7%)
T stageT122 (14.5%)17 (10.3%)0.320
T244 (28.9%)51 (30.9%)
T374 (48.7%)90 (54.5%)
T412 (7.9%)7 (4.2%)
N stageN094 (61.8%)99 (60.0%)0.056
N137 (24.3%)28 (17.0%)
N221 (13.8%)38 (23.0%)
Tumor depositNegative118 (77.6%)137 (83.0%)0.226
Positive34 (22.4%)28 (17.0%)
Lymphovascular invasionNegative91 (59.9%)100 (60.6%)0.893
Positive61 (40.1%)65 (39.4%)
Perineural invasionNegative106 (69.7%)117 (70.9%)0.819
Positive46 (30.3%)48 (29.1%)
Tumor buddingNegative114 (75.0%)126 (76.4%)0.777
Positive38 (25.0%)39 (23.6%)
CEANegative107 (70.4%)115 (69.7%)0.892
Positive45 (29.6%)50 (30.3%)
CA19-9Negative126 (82.9%)126 (76.4%)0.150
Positive26 (17.1%)39 (23.6%)

BMI: body mass index; CEA: carcinoembryonic antigen; CA19-9: carbohydrate antigen 19-9. Preoperative blood samples.